Cargando…

How important is the second dose of the COVID-19 mRNA vaccine?

Detalles Bibliográficos
Autor principal:	Liu, Anne Y.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Academy of Allergy, Asthma & Immunology 2021
Materias:	Correspondence and Reply
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8181744/ https://www.ncbi.nlm.nih.gov/pubmed/34112480 http://dx.doi.org/10.1016/j.jaip.2021.02.061

Ejemplares similares

Reply to “How important is the second dose of the COVID-19 mRNA vaccine?”
por: Shaker, Marcus S., et al.
Publicado: (2021)

Variability of eliciting thresholds in PEG allergy limits prediction of tolerance to PEG-containing mRNA COVID vaccines
por: Mathes, Sonja, et al.
Publicado: (2022)

Reply to “Variability of eliciting thresholds in PEG allergy limits prediction of tolerance to PEG-containing mRNA COVID vaccines”
por: Picard, Matthieu, et al.
Publicado: (2022)

Antibody Persistence through 6 Months after the Second Dose of mRNA-1273 Vaccine for Covid-19
por: Doria-Rose, Nicole, et al.
Publicado: (2021)

Current Data on COVID-19 mRNA-Vaccine Safety during Pregnancy Might Be Subject to Selection Bias. Reply to Stroobandt, S.; Stroobandt, R. Data of the COVID-19 mRNA-Vaccine V-Safe Surveillance System and Pregnancy Registry Reveals Poor Embryonic and Second Trimester Fetal Survival Rate. Comment on “Stuckelberger et al. SARS-CoV-2 Vaccine Willingness among Pregnant and Breastfeeding Women during the First Pandemic Wave: A Cross-Sectional Study in Switzerland. Viruses 2021, 13, 1199”
por: Stuckelberger, Sarah, et al.
Publicado: (2021)

Reply to Çınar et al. Comment on “Zamfir et al. Hematologic Malignancies Diagnosed in the Context of the mRNA COVID-19 Vaccination Campaign: A Report of Two Cases. Medicina 2022, 58, 874”
por: Caruntu, Ana, et al.
Publicado: (2022)

PEG skin testing for COVID-19 vaccine allergy
por: Stone, Bryan D.
Publicado: (2021)

Psoriatic arthritis flare-up after a second dose of BNT162b2 COVID-19 mRNA vaccine
por: Watabe, Daisuke, et al.
Publicado: (2022)

Efficacy of a Fourth Dose of Covid-19 mRNA Vaccine against Omicron
por: Regev-Yochay, Gili, et al.
Publicado: (2022)

Three Doses of an mRNA Covid-19 Vaccine in Solid-Organ Transplant Recipients
por: Kamar, Nassim, et al.
Publicado: (2021)

Aphasia seven days after second dose of an mRNA-based SARS-CoV-2 vaccine
por: Finsterer, Josef, et al.
Publicado: (2021)

Antibody persistence 100 days following the second dose of BNT162b mRNA Covid19 vaccine in patients with chronic lymphocytic leukemia
por: Tadmor, Tamar, et al.
Publicado: (2021)

Myocarditis after Covid-19 mRNA Vaccination
por: Verma, Amanda K., et al.
Publicado: (2021)

Three Doses of Hepatitis B Vaccine or Four Doses in Chronic Renal Failure
por: Khazaeipour, Zahra, et al.
Publicado: (2013)

Receipt of mRNA Covid-19 Vaccines and Risk of Spontaneous Abortion
por: Zauche, Lauren H., et al.
Publicado: (2021)

Supraglottitis as the sole manifestation of COVID-19 in a patient who received two doses of mRNA vaccine
por: Chang, Kai-Ming, et al.
Publicado: (2022)

VITT and Second Doses of Covid-19 Vaccine
por: Lacy, Joanne, et al.
Publicado: (2021)

Comparative immunogenicity of mRNA and inactivated vaccines against COVID-19
por: Lim, Wey Wen, et al.
Publicado: (2021)

Mortality-related immune features and COVID-19
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2021)

Authors’ reply: the biologic importance of the vitamin D binding protein polymorphism in pediatric COVID-19 patients
por: Bayramoğlu, Elvan, et al.
Publicado: (2021)

Bivalent COVID-19 mRNA vaccine against omicron subvariants in immunocompromised patients
por: Solera, Javier T, et al.
Publicado: (2023)

Reply to “PEG skin testing for COVID-19 allergy”
por: Banerji, Aleena, et al.
Publicado: (2021)

Reply to “Mortality-related immune features and COVID-19”
por: Cai, Li, et al.
Publicado: (2021)

Importance of nasal secretions in the evaluation of mucosal immunity elicited by mRNA BNT162b2 COVID-19 Vaccine
por: Francavilla, Beatrice, et al.
Publicado: (2022)

Temporal relation between second dose BNT162b2 mRNA Covid-19 vaccine and cardiac involvement in a patient with previous SARS-COV-2 infection
por: Ammirati, Enrico, et al.
Publicado: (2021)

Does asthma affect outcomes of patients with COVID-19 infections?
por: Kalemci, Serdar, et al.
Publicado: (2021)

COVID-19 “infodemics” and asthmatic children: The return to school challenge
por: Boechat, José Laerte, et al.
Publicado: (2021)

Fulminant myocarditis after the second dose of COVID‐19 mRNA vaccination
por: Oka, Akihiro, et al.
Publicado: (2022)

Reply to “Does asthma affect outcomes of patients with COVID-19 infections?”
por: Mahdavinia, Mahboobeh, et al.
Publicado: (2021)

Safety and tolerability of mRNA COVID-19 vaccines in people with antiphospholipid antibodies
por: Sciascia, Savino, et al.
Publicado: (2021)

Severe bullous drug reaction after COVID‐19 mRNA vaccination
por: Irmer, Marie Luise, et al.
Publicado: (2022)

Patient variability in severity of COVID-19 disease. Main suspect: vascular endothelium
por: Tricarico, Gerardo, et al.
Publicado: (2021)

Reply to “The forced renaissance of telemedicine during COVID-19: A fellow-in-training's perspective”
por: Bansal, Priya, et al.
Publicado: (2021)

Benralizumab: A potential tailored treatment for life-threatening DRESS in the COVID-19 era
por: Mesli, Farah, et al.
Publicado: (2021)

Protective effects of eosinophils against COVID-19: More than an ACE(2) in the hole?
por: Drake, Matthew G., et al.
Publicado: (2021)

Reply to “Patient variability in severity of COVID-19 disease. Main suspect: vascular endothelium”
por: Ballow, Mark, et al.
Publicado: (2021)

Different effect of inhaled and systemic corticosteroids on the outcome of COVID-19 among patients with asthma
por: Hsu, Chi-Kuei, et al.
Publicado: (2022)

Reply to “Benralizumab: A potential tailored treatment for life-threatening DRESS in the COVID-19 era”
por: Lang, Claudia Cécile Valérie, et al.
Publicado: (2021)

Reply to “Protective effects of eosinophils against COVID-19: More than an ACE(2) in the hole?”
por: Ferastraoaru, Denisa, et al.
Publicado: (2021)

Reply to “Different effect of inhaled and systemic corticosteroids on the outcome of COVID-19 among patients with asthma”
por: Feng, Lan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_do5bc0v6qsevf23vf8dbhb33jl